Skip to content

Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging

Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04725162
Enrollment
234
Registered
2021-01-26
Start date
2014-07-01
Completion date
2021-06-30
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

Epilepsy, Peidatrics, Positron emission tomography (PET)

Brief summary

This retrospective study aimed to develop a new approach for automatic localization of epilepsy foci in children with epilepsy.

Detailed description

This retrospective study aimed to develop a new approach for automatic localization of epilepsy foci in children with intractable epilepsy. Pediatric patients with intractable epilepsy would be retrospectively included in this study. The inclusion criteria included (1) age between 6 and 18 y; (2) detailed seizure semiology evaluation, MRI, EEG and interictal 18F-FDG PET/CT examination; (3) clinical diagnosis as focal epilepsy. The exclusion criteria included (a) any history of central nervous system disease; (b) poor image quality due to head movement.

Interventions

RADIATION18F-FDG

All subjects received 18F-FDG PET examination.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 1\. age between 6 and 18 years. * 2\. detailed presurgical evaluation, including seizure semiology evaluation, MRI, EEG and interictal 18F-FDG PET/Computer Tomography (CT) examination. * 3\. clinical diagnosis as focal epilepsy.

Exclusion criteria

* 1\. any history of central nervous system (CNS) disease such as trauma and CNS tumor. * 2\. poor image quality due to head movement.

Design outcomes

Primary

MeasureTime frameDescription
AccuracyThrough study completion, about 6 monthsThe accuracy of epilepsy focus localization.
KappaThrough study completion, about 6 monthsThe agreement between experiment result and clinical diagnosis.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026